rs3209079

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_013382.7(POMT2):​c.1911T>G​(p.Leu637Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.807 in 1,613,018 control chromosomes in the GnomAD database, including 526,421 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 51439 hom., cov: 33)
Exomes 𝑓: 0.81 ( 474982 hom. )

Consequence

POMT2
NM_013382.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.748
Variant links:
Genes affected
POMT2 (HGNC:19743): (protein O-mannosyltransferase 2) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT1 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS).[provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.091).
BP6
Variant 14-77278850-A-C is Benign according to our data. Variant chr14-77278850-A-C is described in ClinVar as [Benign]. Clinvar id is 166901.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-77278850-A-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.748 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.929 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POMT2NM_013382.7 linkc.1911T>G p.Leu637Leu synonymous_variant Exon 19 of 21 ENST00000261534.9 NP_037514.2 Q9UKY4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POMT2ENST00000261534.9 linkc.1911T>G p.Leu637Leu synonymous_variant Exon 19 of 21 1 NM_013382.7 ENSP00000261534.4 Q9UKY4-1

Frequencies

GnomAD3 genomes
AF:
0.821
AC:
124889
AN:
152092
Hom.:
51399
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.838
Gnomad AMI
AF:
0.849
Gnomad AMR
AF:
0.761
Gnomad ASJ
AF:
0.831
Gnomad EAS
AF:
0.951
Gnomad SAS
AF:
0.785
Gnomad FIN
AF:
0.857
Gnomad MID
AF:
0.753
Gnomad NFE
AF:
0.811
Gnomad OTH
AF:
0.833
GnomAD2 exomes
AF:
0.815
AC:
203865
AN:
250248
AF XY:
0.814
show subpopulations
Gnomad AFR exome
AF:
0.842
Gnomad AMR exome
AF:
0.737
Gnomad ASJ exome
AF:
0.819
Gnomad EAS exome
AF:
0.964
Gnomad FIN exome
AF:
0.847
Gnomad NFE exome
AF:
0.814
Gnomad OTH exome
AF:
0.814
GnomAD4 exome
AF:
0.805
AC:
1176648
AN:
1460808
Hom.:
474982
Cov.:
72
AF XY:
0.805
AC XY:
584837
AN XY:
726742
show subpopulations
Gnomad4 AFR exome
AF:
0.844
AC:
28235
AN:
33460
Gnomad4 AMR exome
AF:
0.747
AC:
33376
AN:
44690
Gnomad4 ASJ exome
AF:
0.823
AC:
21511
AN:
26132
Gnomad4 EAS exome
AF:
0.967
AC:
38376
AN:
39698
Gnomad4 SAS exome
AF:
0.772
AC:
66545
AN:
86244
Gnomad4 FIN exome
AF:
0.845
AC:
44635
AN:
52850
Gnomad4 NFE exome
AF:
0.801
AC:
890377
AN:
1111610
Gnomad4 Remaining exome
AF:
0.812
AC:
49003
AN:
60360
Heterozygous variant carriers
0
15325
30650
45974
61299
76624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20774
41548
62322
83096
103870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.821
AC:
124983
AN:
152210
Hom.:
51439
Cov.:
33
AF XY:
0.823
AC XY:
61244
AN XY:
74428
show subpopulations
Gnomad4 AFR
AF:
0.838
AC:
0.8379
AN:
0.8379
Gnomad4 AMR
AF:
0.760
AC:
0.760201
AN:
0.760201
Gnomad4 ASJ
AF:
0.831
AC:
0.830933
AN:
0.830933
Gnomad4 EAS
AF:
0.951
AC:
0.951257
AN:
0.951257
Gnomad4 SAS
AF:
0.785
AC:
0.78459
AN:
0.78459
Gnomad4 FIN
AF:
0.857
AC:
0.856672
AN:
0.856672
Gnomad4 NFE
AF:
0.811
AC:
0.810691
AN:
0.810691
Gnomad4 OTH
AF:
0.836
AC:
0.836011
AN:
0.836011
Heterozygous variant carriers
0
1187
2375
3562
4750
5937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
882
1764
2646
3528
4410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.812
Hom.:
42595
Bravo
AF:
0.816
Asia WGS
AF:
0.874
AC:
3042
AN:
3478
EpiCase
AF:
0.809
EpiControl
AF:
0.811

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu637Leu in exon 19 of POMT2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 19.0% (1637/8600) o f European American chromosomes from a broad population by the NHLBI Exome Seque ncing Project (http://evs.gs.washington.edu/EVS; dbSNP rs3209079). -

Jun 05, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2;C3150416:Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2;C3150418:Autosomal recessive limb-girdle muscular dystrophy type 2N Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2N Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
5.7
DANN
Benign
0.55
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3209079; hg19: chr14-77745193; COSMIC: COSV55071450; COSMIC: COSV55071450; API